- Home
- HCAT vs TARA Comparison
HCAT vs TARA Comparison
Compare HCAT & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCAT
- TARA
- Stock Information
- Founded
- HCAT 2008
- TARA N/A
- Country
- HCAT United States
- TARA United States
- Employees
- HCAT N/A
- TARA N/A
- Industry
- HCAT Computer Software: Programming Data Processing
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HCAT Technology
- TARA Health Care
- Exchange
- HCAT Nasdaq
- TARA Nasdaq
- Market Cap
- HCAT 186.5M
- TARA 220.7M
- IPO Year
- HCAT 2019
- TARA N/A
- Fundamental
- Price
- HCAT $3.05
- TARA $5.49
- Analyst Decision
- HCAT Hold
- TARA Strong Buy
- Analyst Count
- HCAT 11
- TARA 6
- Target Price
- HCAT $4.50
- TARA $19.80
- AVG Volume (30 Days)
- HCAT 462.2K
- TARA 894.9K
- Earning Date
- HCAT 11-05-2025
- TARA 11-11-2025
- Dividend Yield
- HCAT N/A
- TARA N/A
- EPS Growth
- HCAT N/A
- TARA N/A
- EPS
- HCAT N/A
- TARA N/A
- Revenue
- HCAT $316,093,000.00
- TARA N/A
- Revenue This Year
- HCAT $4.52
- TARA N/A
- Revenue Next Year
- HCAT $0.57
- TARA N/A
- P/E Ratio
- HCAT N/A
- TARA N/A
- Revenue Growth
- HCAT 5.55
- TARA N/A
- 52 Week Low
- HCAT $2.52
- TARA $1.77
- 52 Week High
- HCAT $9.24
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- HCAT 52.43
- TARA 69.65
- Support Level
- HCAT $2.61
- TARA $5.20
- Resistance Level
- HCAT $3.10
- TARA $5.92
- Average True Range (ATR)
- HCAT 0.14
- TARA 0.37
- MACD
- HCAT 0.04
- TARA 0.06
- Stochastic Oscillator
- HCAT 84.69
- TARA 75.82
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).